Hearing News Watch

BALLERUP, DENMARK — GN Hearing had a very strong finish to the year with 14% organic revenue growth in Q4 2022 driven by significant market share gains as a result of the successful ReSound OMNIA launch. Consequently, GN Hearing delivered 5% organic revenue growth in 2022, in line with the financial guidance. Revenue growth was 17% including around 7% impact

CARLSBAD, CALIFORNIA — Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today provided an update on its auditory neuronal cell therapy program (ANP1), for the treatment of hearing loss, with an initial focus on auditory neuropathy spectrum disorders. Preclinical testing of ANP1 has begun through a collaboration

NEW YORK, NEW YORK —Tuned, a digital hearing health company focused on providing hearing care for all, today announced that it raised $3.5 million in funding led by Distributed Ventures with participation from Idealab NY, and Elements Health Ventures. The funding will support Tuned’s mission to make comprehensive hearing care as affordable and accessible as possible while enabling the platform to be offered as

FRANKFURT AM MAIN/MAINZ, GERMANY — The 67th International Congress of Hearing Aid Acousticians is scheduled to be held in Nuremberg, Germany, from October 18 to 20, 2023. The Congress and the International Industry Exhibition will again be an opportunity to network and discover new product highlights at the world’s largest meeting of the hearing aid acoustics and hearing instruments industry.

LYNGE, DENMARK – WS Audiology today announced financial performance in line with guidance in Q1 of the fiscal year 2022/23 (October 1st – December 31st, 2022). Highlights Q1 2022/23 WSA revenue grew by 4% to EUR 608 million (1% organic growth) driven by continued strong growth in Managed Care and market share gain in a key account in the US,

NAERUM, DENMARK — The Ida Institute has announced that it has been unable to secure future funding and is therefore significantly scaling back activities. The Denmark-based nonprofit was founded in 2007 with a grant from William Demant Foundation with the goal of bringing person-centered care to hearing healthcare. The institute was in the unique position of receiving full funding from William

On Monday, February 6, all Texas Roadhouse and Bubba’s 33 locations will donate 100 percent of the day’s profits to the American Tinnitus Association (ATA) in honor of the company’s late founder, Kent Taylor. The public is invited to show their support by dining (or ordering to-go) at any Texas Roadhouse or Bubba’s 33 location on February 6, which marks the first day of

SANTA FE, NEW MEXICO — A bill has recently been introduced in the state legislature of New Mexico that would require captions be turned on at all times during business hours on what are considered public TVs while the devices are in operation. This would include television sets in bars, restaurants, waiting rooms, gyms and other locations where the TVs

RESEARCH TRIANGLE PARK, NORTH CAROLINA — Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Exclusivity to PEDMARK® (sodium thiosulfate injection), which is indicated to reduce the risk of ototoxicity, or hearing loss, associated with cisplatin use in pediatric patients one month of

MONTPELLIER, FRANCE – Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, and EVEON, designer and manufacturer of custom medical devices for the preparation and delivery of drugs, announce they have been collaborating to design and develop an injection system